🇺🇸 FDA
Patent

US 8101740

Positron emission tomography probes for imaging immune activation and selected cancers

granted A61KA61K51/0491A61P

Quick answer

US patent 8101740 (Positron emission tomography probes for imaging immune activation and selected cancers) held by The Regents of the University of California expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K51/0491, A61P, A61P19/02